<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_EPFL_Results_Aptamers skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:EPFL/Results/Aptamers</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="apta-menu-bar"><P style="float:right; color:white; padding-right:60px;padding-top:10px;" class="apta-menu-icon"><B>MENU</B></P></DIV><DIV class="apta-wrapper"><DIV class="apta-menu-item"><UL><LI class="main-submenu-item"><A href="https://2017.igem.org/Team:EPFL">Home</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Project</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description">Overview</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Summary">Results overview</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Outlook">Outlook</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Team</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Team">Our team</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Attributions">Attributions</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Collaborations">Collaborations</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Human practices</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP">Overview</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Mini-Kit">Educational CF Kit- Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Mini-Kit/Storyline">Educational CF Kit - The Project</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Lysates</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Lysates">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Lysates">Results</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Lysates/Catalog">Catalog</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Aptamers</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Parts/Description">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Aptamers">Microfluidics</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Aptamers">Microfluidics - Results</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Beads">Beads</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Aptamers2">Beads - Results</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Toehold</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Toehold">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Toehold">Results- Trigger Modularity</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Toehold/Signal_Generation">Results - Signal Generation</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Software</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Software">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Software/Demo">Results</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Lab</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Safety">Safety</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Protocols">Protocols</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Notebook">Notebook</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Parts">Parts</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Medal requirements</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Attributions">Attributions</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Collaborations">Collaborations</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Contribution">Contribution</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Silver">Silver</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Gold_Integrated">Gold Integrated</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Demonstrate">Proof of Concept</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Improve">Improvement</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Prizes</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Engagement">Education &amp; Public Engagement</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Software">Software</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Applied_Design">Applied Design</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Gold_Integrated">Integrated Human Practices</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Contact</LI><LI class="sec-submenu-item">epfl.igem2017@gmail.com</LI><LI class="sec-submenu-item"><I><A href="https://www.facebook.com/igemepfl/?fref=ts" class="fa fa-facebook fa-2x">facebook</A></I></LI><LI class="sec-submenu-item"><I><A href="https://twitter.com/epfl_igem?lang=en" class="fa fa-twitter fa-2x">twitter</A></I></LI></UL></DIV></DIV><DIV class="text-center top-space center-block" style="width:60%"><H1 class="top-space bottom-space"> Microfluidics results in a nutshell</H1><UL style="list-style:disc"><LI> Thrombin aptamers 1, 2 and 3 bind α-Human Thrombin in buffer </LI><LI> Thrombin aptamers 1 and 2 can detect α-Human Thrombin in a sandwich 
						assay in buffer </LI><LI> Thrombin aptamers 1 and 3 can detect α-Human Thrombin in a sandwich 
						assay in buffer </LI><LI> Thrombin can be detected in Human serum using both thrombin aptamers 
						1 and 3</LI><LI> PDGF aptamers 1 and 2 can detect PDGF in a sandwich assay in buffer</LI></UL><H2 class="top-space"> Thrombin aptamer binding test </H2><P>We tested the affinity of our Thrombin aptamer 1 (Cy5) and our Thrombin 
			aptamer 2 (Cy3) with biotinylated human thrombin. This experiment was done 
			on a MITOMI 768 chip flowing biotinylated human thrombin and then the two 
			aptamers in different parts of the chip in order to see whether they bind 
			with thrombin. The affinity is measured by the relative fluorescence in the 
			different channels (Cy3 and Cy5). As a negative control, both Cy3 and Cy5 labeled DNA oligos with a random sequence were flown instead of the aptamer in half of the chip to make sure thrombin does not have non-specific binding.</P><P>A fluorescent scan of the microfluidic chip after wash resulted in a 
				fluorescent signal in both Cy5 and Cy3 channels (Fig. 1a and 1b) in the 
				button area for the aptamers and no signal for the control as expected.</P><FIGURE><FIGCAPTION><B>Figure 1a:</B> Thrombin aptamer 1 binding test</FIGCAPTION></FIGURE><FIGURE><FIGCAPTION><B>Figure 1b:</B> Thrombin aptamer 2 binding test</FIGCAPTION></FIGURE><H2 class="top-space bottom-space">Finding the relative Kds of our 
				aptamers with thrombin in terms of RFU</H2><P>We spotted on an epoxy-coated glass slide different concentrations of Cy5-labeled Thrombin aptamer 1 and Cy3-labeled Thrombin aptamer 2, ranging from 2 μM to 0.2 μM, for MITOMI experiments. Cy3 and Cy5 labeled DNA oligos were again used as negative controls. Both aptamers were 
				resuspended and incubated for 1 hour to obtain a saturation binding curve. 
				As expected, the fluorescent signal increases with aptamer concentration. </P><P> After data analysis, we obtain two hyperbolic saturation binding curve 
				(Fig. 2a and 2b).
The best statistical model was found to be a simple one-binding site model ($E_{max}$ model):
$y_i = \frac{B \times x_i}{K_d + x_i} + \epsilon_i$ with $i \in \{ 1,...,N\} $. 
$x_i$ denotes the aptamer concentration in solution, $y_i$ the aptamer-protein complex 
concentration and $N$ the number of observations. The residual errors are assumed 
to be identically and independently distributed $\epsilon_i \sim N(0, \sigma^2)$ .</P><DIV class="row"><FIGURE class="col-md-6"><FIGCAPTION><B>Figure 2a:</B> Thrombin aptamer 2, α-Human Thrombin saturation curve </FIGCAPTION></FIGURE><FIGURE class="col-md-6"><FIGCAPTION><B>Figure 2b:</B> Thrombin aptamer 1, α-Human Thrombin saturation curve</FIGCAPTION></FIGURE></DIV><H2 class="top-space bottom-space"> Sandwich assay with our Thrombin aptamers 
	1 and 2 in buffer</H2><P>The Thrombin aptamer 1 is now biotinylated rather than Cy5 labeled, enabling it to be fixed to the surface. To begin the biotinylated aptamer 1 was flown, then human thrombin in half of the chip and finally the whole chip was covered with Cy3 thrombin aptamer 2. As expected, a signal in the button area was observed in the region containing containing the first aptamer, thrombin and the second Cy3 labeled aptamer. Washing steps were done 
	with PBS and Aptamer Binding buffer (ABB, cf. protocols).</P><P>A fluorescent scan of the microfluidic chip resulted in a fluorescent signal 
	in the upper part of the chip where Thrombin was flown (Fig. 3).</P><FIGURE><FIGCAPTION><B>Figure 3:</B> Sandwich assay with Thrombin aptamers 1 and 2 in buffer</FIGCAPTION></FIGURE><H2 class="top-space bottom-space"> Sandwich assay with our Thrombin aptamers 
	1 and 3 in buffer</H2><P>The Thrombin aptamer 3 is a modified version of the Thrombin aptamer 2 containing 
	the short trigger sequence for the toehold. We tested if this aptamer could still 
	form a sandwich complex with human thrombin and the biotinylated Thrombin aptamer 1. 
	Briefly, the biotinylated Thrombin aptamer 1 was first flown, then human thrombin in 
	the top half of the chip and finally the Cy3-labeled Thrombin aptamer 3 in the whole 
	chip. </P><P>As expected, no conformational change is impacting the modified aptamer to bind 
	to human thrombin (Fig. 4).</P><FIGURE><FIGCAPTION><B>Figure 4:</B> Sandwich assay with Thrombin aptamers 1 and 3 in buffer</FIGCAPTION></FIGURE><H2 class="top-space bottom-space">Sandwich assay with our Thrombin aptamers 
	1 and 3 in human serum </H2><P> We tested whether our aptamer pair could form a sandwich with thrombin in human 
	serum. The thrombin aptamer 1 which is biotinylated is flown first and thereby fixed to the surface.
  Human serum was then flown in half of the chip and finally the 
	whole chip was covered with the Cy3-labeled thrombin aptamer 2. 
	Washing steps were performed with a buffer (PBS + 2% BSA + 0.01% Tween 20). 
	As expected, a signal in the button area was observed in the region containing 
	human serum. </P><FIGURE><FIGCAPTION><B>Figure 5:</B> Sandwich assay with PDGF aptamers 1 and 2 in buffer</FIGCAPTION></FIGURE><H2 class="top-space bottom-space">Sandwich assay with our PDGF aptamer 1 and 2  in buffer</H2><P> We tested whether our PDGF aptamer 1 and 2 pair could form a sandwich with
		PDGF-BB. Briefly, the first biotinylated PDGF aptamer 1 was flown, then PDGF-BB 
		in half of the chip and finally the whole chip was covered with Cy3-labeled PDGF 
		aptamer 2. As expected, a signal in the button area was observed in the region 
		containing Cy3 labeled aptamer. Washing steps were done with PBS and aptamer 
		Binding buffer (ABB, cf. protocols) A fluorescent scan of the microfluidic 
		chip resulted in a fluorescent signal in the upper part of the chip where PDGF 
		was flown (Fig. 6). </P><FIGURE><FIGCAPTION><B>Figure 6:</B> Sandwich assay with PDGF aptamers 1 and 2 in buffer</FIGCAPTION></FIGURE></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>